5
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Prognostic Factors in Myelofibrosis

, &
Pages 455-461 | Published online: 06 Jul 2009

References

  • Bouroncle B. A., Doan C. A. F. Myelofibrosis: Clinical, hematologic and pathologic study of 110 patients. Am. J. Med. Sci. 1965; 243: 697–715
  • Marciniak R., Szezeklik A. Multiformity of the clinical picture in a case of osteomyelosclerosis. Pol. Arch. Med. Wewn. 1965; 35: 573–576
  • Ward H. P., Block M. H. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1971; 50: 357–420
  • Takaczi-Nagy L., Graf F. Definition, clinical features and diagnosis of myelofibrosis. Clin. Haematol. 1975; 4: 373–392
  • Rosenthal D. S., Moloney W. C. Myeloid metaplasia: A study of 98 cases. Postgrad. Med. 1969; 45: 136–142
  • Silverstein M. N. Agnogenic Myeloid Metaplasia. Publishing Sciences Group, Acton 1975
  • Meytes D., Katz D., Ramot B. Prognostic parameters in myeloid metaplasia: Agnogenic vs. postpolycythemic. Isr. J. Med. Sci. 1976; 12: 534–540
  • Benbassat J., Penchas S. Early splenectomy and survival in agnogenic myeloid metaplasia: An analysis of 338 cases published since 1940. Acta Haematol. 1981; 65: 189–192
  • Nassar T. K., Shanklin W. M. Simplified procedure for staining reticulum. Arch. Pathol. 1961; 71: 611–614
  • Gurr E. A Practical Manual of Medical and Biological Staining Techniques. Interscience Publishers Inc., New York 1956
  • Armitage P. Statistical Methods in Medical Research. Blackwell Scientific Publications, Oxford 1971
  • Bradley J. V. Distribution-Free Statistical Tests. Prentice-Hall, Englewood Cliffs, N.J. 1968
  • Skinner H. C., Sophean L. S. Agnogenic myeloid metaplasia of the spleen: Follow-up after splenectomy. J. Internat. Coll. Surgeons 1951; 15: 343–346
  • Adamson J. W., Fialkow P. J. The pathogenesis of myeloproliferative syndromes. Br. J. Haematol. 1978; 38: 299–303
  • Jacobson R. J., Salo A., Fialkow P. J. Agnogenic myeloid metaplasia: A clonal proliferation of hemopoietic stem cells with secondary myelofibrosis. Blood 1978; 51: 189–194
  • Editorial. Myelofibrosis. Lancet 1980; i: 127–129
  • Wyatt J. P., Sommers S. C. Chronic marrow failure, myelosclerosis and extramedullary hematopoiesis. Blood 1950; 5: 329–347
  • Leonard B. J., Israels M. C. B., Wilkinson J. F. Myelosclerosis: A clinicopathological study. Q. J. Med. 1957; 26: 131–147
  • Chelloul N., Jacquillat C., Brier J., et al. Prognostic value of osteo-medullary lesions in primitive myeloid splenomegaly (Fr.). Nouve. Presse Med. 1975; 4: 3060–3062
  • Adamson J. W., Singer J. W., Catalalano P., et al. Polycythemia Vera: Further in vitro studies of hematopoietic regulation. J. Clin. Inv. 1980; 66: 1363–1368
  • El-Maallem H., Fletcher J. Impaired neutrophil function and myeloperoxidase deficiency in myeloid metaplasia. Br. J. Haematol. 1977; 37: 323–329
  • Weinfeld A., Branehog I., Kutti J. Platelets in the myeloproliferative syndrome. Clin. Haematol. 1979; 4: 373–392
  • Phadke K., Dean S., Pitney W. R. Platelet dysfunction in myeloproliferative syndromes. Am. J. Hematol. 1981; 10: 57–64
  • Kuo C., Van Voolen A. G., Morrison A. N. Primary and secondary myelofibrosis. Its relationship to ‘PNH-like defect’. Blood 1972; 40: 875–879
  • Groopman J. E. The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann. Intern. Med. 1980; 92: 857–858

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.